Results
|
21.
|
|
|
22.
|
|
|
23.
|
|
|
24.
|
|
|
25.
|
|
|
26.
|
|
|
27.
|
|
|
28.
|
|
|
29.
|
|
|
30.
|
|
|
31.
|
|
|
32.
|
|
|
33.
|
|
|
34.
|
|
|
35.
|
|
|
36.
|
|
|
37.
|
Does the Fuhrman or World Health Organization/International Society of Urological Pathology Grading System Apply to the Xp11.2 Translocation Renal Cell Carcinoma?: A 10-Year Single-Center Study. [electronic resource] by
- Liu, Ning
- Gan, Weidong
- Qu, Feng
- Wang, Zhen
- Zhuang, Wenyuan
- Agizamhan, Sezim
- Xu, Linfeng
- Yin, Juanjuan
- Guo, Hongqian
- Li, Dongmei
Producer: 20190415
In:
The American journal of pathology vol. 188
Availability: No items available.
|
|
38.
|
Tumour location determined by preoperative MRI is an independent predictor for positive surgical margin status after Retzius-sparing robot-assisted radical prostatectomy. [electronic resource] by
- Li, Youjian
- Fu, Yao
- Li, Weijian
- Xu, Linfeng
- Zhang, Qing
- Gao, Jie
- Li, Danyan
- Li, Xiaogong
- Qiu, Xuefeng
- Guo, Hongqian
Producer: 20201130
In:
BJU international vol. 126
Availability: No items available.
|
|
39.
|
Gambogenic acid inhibits fibroblast growth factor receptor signaling pathway in erlotinib-resistant non-small-cell lung cancer and suppresses patient-derived xenograft growth. [electronic resource] by
- Xu, Linfeng
- Meng, Xiaoxiao
- Xu, Naihan
- Fu, Wenwei
- Tan, Hongsheng
- Zhang, Li
- Zhou, Qianjun
- Qian, Jianan
- Tu, Shiwei
- Li, Xueting
- Lao, Yuanzhi
- Xu, Hongxi
Producer: 20200406
In:
Cell death & disease vol. 9
Availability: No items available.
|
|
40.
|
Incidence and significance of psammoma bodies in Xp11.2 translocation renal cell carcinoma and papillary renal cell carcinoma. [electronic resource] by
- Liu, Ning
- Qu, Feng
- Wei, Kang
- Gan, Weidong
- Wang, Zhen
- Zhuang, Wenyuan
- Agizamhan, Sezim
- Ma, Wenliang
- Yang, Jun
- Chen, Ming
- Xu, Linfeng
- Guo, Hongqian
- Li, Dongmei
Publication details: Oncology letters Jul 2019
In:
Oncology letters vol. 18
Availability: No items available.
|